Antimycobacterial activity of novel 1-(5-cyclobutyl-1,3-oxazol-2-yl)-3-(sub)phenyl/pyridylthiourea compounds endowed with high activity toward multidrug-resistant Mycobacterium tuberculosis
Author(s) -
Dharmarajan Sriram,
Perumal Yogeeswari,
Murugesan Dinakaran,
Rathinasababathy Thirumurugan
Publication year - 2007
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkm085
Subject(s) - antimycobacterial , isoniazid , in vivo , mycobacterium tuberculosis , in vitro , tuberculosis , mycobacterium , chemistry , microbiology and biotechnology , multiple drug resistance , pharmacology , biology , medicine , antibiotics , biochemistry , pathology
The objective of this work was to synthesize 15 new 1-(5-cyclobutyl-1,3-oxazol-2-yl)-3-(sub)phenyl/pyridylthiourea compounds and evaluate their in vitro and in vivo antimycobacterial activities.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom